| 0 |
INCREASED NEED FOR SLEEP |
1 |
0.0046 |
| 1 |
DIAPHRAGMATIC PARALYSIS |
1 |
0.0017 |
| 2 |
CORNEAL PERFORATION |
1 |
0.0016 |
| 3 |
DYSBIOSIS |
1 |
0.0013 |
| 4 |
PRODUCT AFTER TASTE |
1 |
0.0011 |
| 5 |
DRUG EFFECT LESS THAN EXPECTED |
15 |
0.0011 |
| 6 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
30 |
0.0010 |
| 7 |
CHRONIC RESPIRATORY FAILURE |
1 |
0.0009 |
| 8 |
OBLITERATIVE BRONCHIOLITIS |
1 |
0.0008 |
| 9 |
PNEUMOMEDIASTINUM |
1 |
0.0006 |
| 10 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
2 |
0.0005 |
| 11 |
CATHETER SITE PAIN |
1 |
0.0004 |
| 12 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
27 |
0.0004 |
| 13 |
ULCERATIVE KERATITIS |
1 |
0.0004 |
| 14 |
KERATITIS |
1 |
0.0003 |
| 15 |
DEFAECATION URGENCY |
2 |
0.0003 |
| 16 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 17 |
PRODUCT SOLUBILITY ABNORMAL |
1 |
0.0002 |
| 18 |
UNDERDOSE |
13 |
0.0002 |
| 19 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0002 |
| 20 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 21 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 22 |
ULCER HAEMORRHAGE |
1 |
0.0001 |
| 23 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
8 |
0.0001 |
| 24 |
SENSITIVE SKIN |
1 |
0.0001 |
| 25 |
FEELING DRUNK |
1 |
0.0001 |
| 26 |
DRUG SCREEN POSITIVE |
1 |
0.0001 |
| 27 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 28 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 29 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 30 |
NOCTURIA |
1 |
0.0001 |
| 31 |
BRAIN OEDEMA |
1 |
0.0001 |
| 32 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 33 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 34 |
PNEUMOTHORAX |
1 |
0.0001 |
| 35 |
PERICARDITIS |
1 |
0.0001 |
| 36 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 37 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 38 |
KIDNEY INFECTION |
1 |
0.0001 |
| 39 |
EXTRA DOSE ADMINISTERED |
2 |
0.0001 |
| 40 |
INTENTIONAL SELF-INJURY |
1 |
0.0001 |
| 41 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 42 |
OVERDOSE |
10 |
0.0000 |
| 43 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 44 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 45 |
THROAT IRRITATION |
2 |
0.0000 |
| 46 |
HYPERSENSITIVITY |
8 |
0.0000 |
| 47 |
LIVER INJURY |
1 |
0.0000 |
| 48 |
INCORRECT DOSE ADMINISTERED |
9 |
0.0000 |
| 49 |
INJECTION SITE BRUISING |
3 |
0.0000 |
| 50 |
GASTRITIS |
1 |
0.0000 |
| 51 |
FEAR |
1 |
0.0000 |
| 52 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 53 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 54 |
DRUG INEFFECTIVE |
47 |
0.0000 |
| 55 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
6 |
0.0000 |
| 56 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 57 |
HEPATIC FAILURE |
1 |
0.0000 |
| 58 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 59 |
MOOD SWINGS |
1 |
0.0000 |
| 60 |
CYSTITIS |
1 |
0.0000 |
| 61 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 62 |
DRUG HYPERSENSITIVITY |
5 |
0.0000 |
| 63 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 64 |
CARDIAC FAILURE |
2 |
0.0000 |
| 65 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 66 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 67 |
LIVER DISORDER |
1 |
0.0000 |
| 68 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 69 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 70 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 71 |
SOMNOLENCE |
4 |
0.0000 |
| 72 |
SINUSITIS |
2 |
0.0000 |
| 73 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 74 |
FLATULENCE |
1 |
0.0000 |
| 75 |
SURGERY |
1 |
0.0000 |
| 76 |
NASAL CONGESTION |
1 |
0.0000 |
| 77 |
RHINORRHOEA |
1 |
0.0000 |
| 78 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 79 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 80 |
MOBILITY DECREASED |
1 |
0.0000 |
| 81 |
DYSGEUSIA |
1 |
0.0000 |
| 82 |
HALLUCINATION |
1 |
0.0000 |
| 83 |
HOT FLUSH |
1 |
0.0000 |
| 84 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 85 |
DRUG DEPENDENCE |
2 |
0.0000 |
| 86 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 87 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 88 |
DEVICE ISSUE |
1 |
0.0000 |
| 89 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 90 |
CARDIAC DISORDER |
1 |
0.0000 |
| 91 |
DYSPEPSIA |
1 |
0.0000 |
| 92 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 93 |
HAEMORRHAGE |
1 |
0.0000 |
| 94 |
CONSTIPATION |
2 |
0.0000 |
| 95 |
DEPRESSION |
2 |
0.0000 |
| 96 |
PALPITATIONS |
1 |
0.0000 |
| 97 |
FEELING ABNORMAL |
2 |
0.0000 |
| 98 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 99 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 100 |
INSOMNIA |
2 |
0.0000 |
| 101 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 102 |
ANXIETY |
2 |
0.0000 |
| 103 |
OFF LABEL USE |
6 |
0.0000 |
| 104 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 105 |
HOSPITALISATION |
1 |
0.0000 |
| 106 |
PARAESTHESIA |
1 |
0.0000 |
| 107 |
URTICARIA |
1 |
0.0000 |
| 108 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 109 |
COVID-19 |
1 |
0.0000 |
| 110 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 111 |
CHEST PAIN |
1 |
0.0000 |
| 112 |
ASTHENIA |
2 |
0.0000 |
| 113 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 114 |
HYPERTENSION |
1 |
0.0000 |
| 115 |
DIARRHOEA |
3 |
0.0000 |
| 116 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 117 |
FATIGUE |
3 |
0.0000 |
| 118 |
COUGH |
1 |
0.0000 |
| 119 |
DYSPNOEA |
2 |
0.0000 |
| 120 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 121 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 122 |
HEADACHE |
2 |
0.0000 |
| 123 |
PNEUMONIA |
1 |
0.0000 |
| 124 |
PYREXIA |
1 |
0.0000 |
| 125 |
ARTHRALGIA |
1 |
0.0000 |
| 126 |
RASH |
1 |
0.0000 |
| 127 |
DIZZINESS |
1 |
0.0000 |
| 128 |
PAIN |
1 |
0.0000 |
| 129 |
NAUSEA |
1 |
0.0000 |